Doctors Backing Off Pfizer’s Paxlovid for Lower-Risk COVID Patients

Published on May 28, 2022

Use of Pfizer Inc’s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned  symptoms can recur after people complete a course of the drug.

Read Full Article (External Site)